A citation-based method for searching scientific literature

Eva Coll-de la Rubia, Elena Martinez-Garcia, Gunnar Dittmar, Antonio Gil-Moreno, Silvia Cabrera, Eva Colas. J Clin Med 2020
Times Cited: 29







List of co-cited articles
113 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
31

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Int J Gynecol Cancer 2021
252
27

Endometrial cancer.
Philippe Morice, Alexandra Leary, Carien Creutzberg, Nadeem Abu-Rustum, Emile Darai. Lancet 2016
812
17

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
91
17


A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
348
17

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
135
17

Incorporation of molecular characteristics into endometrial cancer management.
Lisa Vermij, Vincent Smit, Remi Nout, Tjalling Bosse. Histopathology 2020
70
17

Endometrial cancer.
Frederic Amant, Philippe Moerman, Patrick Neven, Dirk Timmerman, Erik Van Limbergen, Ignace Vergote. Lancet 2005
13

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Tjalling Bosse, Remi A Nout, Jessica N McAlpine, Melissa K McConechy, Heidi Britton, Yaser R Hussein, Carlene Gonzalez, Raji Ganesan, Jane C Steele, Beth T Harrison,[...]. Am J Surg Pathol 2018
118
13

TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
Antonio Raffone, Antonio Travaglino, Massimo Mascolo, Luigi Carbone, Maurizio Guida, Luigi Insabato, Fulvio Zullo. Gynecol Oncol 2019
79
13

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.
Felix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran, Annette Staebler, C Blake Gilks, David G Huntsman, Bernhard Krämer, Sara Y Brucker,[...]. Br J Cancer 2018
45
13

Endometrial Cancer.
Karen H Lu, Russell R Broaddus. N Engl J Med 2020
127
13

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
214
13

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
313
13


Type I and II endometrial cancers: have they different risk factors?
Veronica Wendy Setiawan, Hannah P Yang, Malcolm C Pike, Susan E McCann, Herbert Yu, Yong-Bing Xiang, Alicja Wolk, Nicolas Wentzensen, Noel S Weiss, Penelope M Webb,[...]. J Clin Oncol 2013
415
10

Classification of endometrial carcinoma: more than two types.
Rajmohan Murali, Robert A Soslow, Britta Weigelt. Lancet Oncol 2014
327
10

MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Tiechao Jiang, Dongming Sui, Dong You, Songmei Yao, Lirong Zhang, Yingjian Wang, Jixue Zhao, Yaozhong Zhang. Cell Cycle 2018
31
10

MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Hong-Xia Chen, Xiao-Xia Xu, Bu-Zhen Tan, Zhi Zhang, Xiao-Dong Zhou. Cell Physiol Biochem 2017
74
10

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
10

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, J Ledermann, C Marth, R Nout, D Querleu, M R Mirza,[...]. Ann Oncol 2016
514
10

Molecular Genetics of Endometrial Carcinoma.
Daphne W Bell, Lora Hedrick Ellenson. Annu Rev Pathol 2019
74
10

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
10

Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management.
Thilo Dörk, Peter Hillemanns, Clemens Tempfer, Julius Breu, Markus C Fleisch. Cancers (Basel) 2020
15
20

Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.
Antonio Raffone, Antonio Travaglino, Olimpia Gabrielli, Mariacarolina Micheli, Valeria Zuccalà, Giovanna Bitonti, Caterina Camastra, Valentina Gargiulo, Luigi Insabato, Fulvio Zullo. Arch Gynecol Obstet 2021
16
18


The role of biomarkers in endometrial cancer and hyperplasia: a literature review.
Suzanna Hutt, Anil Tailor, Patricia Ellis, Agnieszka Michael, Simon Butler-Manuel, Jayanta Chatterjee. Acta Oncol 2019
30
10

Current recommendations and recent progress in endometrial cancer.
Rebecca A Brooks, Gini F Fleming, Ricardo R Lastra, Nita K Lee, John W Moroney, Christina H Son, Ken Tatebe, Jennifer L Veneris. CA Cancer J Clin 2019
167
10

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Alain G Zeimet, Daniel Reimer, Monica Huszar, Boris Winterhoff, Ulla Puistola, Samira Abdel Azim, Elisabeth Müller-Holzner, Alon Ben-Arie, Léon C van Kempen, Edgar Petru,[...]. J Natl Cancer Inst 2013
139
10


Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Jone Trovik, Elisabeth Wik, Henrica M J Werner, Camilla Krakstad, Harald Helland, Ingrid Vandenput, Tormund S Njolstad, Ingunn M Stefansson, Janusz Marcickiewicz, Solveig Tingulstad,[...]. Eur J Cancer 2013
90
10

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Katherine C Kurnit, Grace N Kim, Bryan M Fellman, Diana L Urbauer, Gordon B Mills, Wei Zhang, Russell R Broaddus. Mod Pathol 2017
125
10

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.
Martin Köbel, Brigitte M Ronnett, Naveena Singh, Robert A Soslow, C Blake Gilks, W Glenn McCluggage. Int J Gynecol Pathol 2019
132
10

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Elena Pereira, Olga Camacho-Vanegas, Sanya Anand, Robert Sebra, Sandra Catalina Camacho, Leopold Garnar-Wortzel, Navya Nair, Erin Moshier, Melissa Wooten, Andrew Uzilov,[...]. PLoS One 2015
91
10

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Henry M Keys, James A Roberts, Virginia L Brunetto, Richard J Zaino, Nick M Spirtos, Jeffrey D Bloss, Andrew Pearlman, Mitchell A Maiman, Jeffrey G Bell. Gynecol Oncol 2004
10

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
10

Clinical actionability of molecular targets in endometrial cancer.
Mary Ellen Urick, Daphne W Bell. Nat Rev Cancer 2019
116
10

Comprehensive miRNA profiling of surgically staged endometrial cancer.
David E Cohn, Muller Fabbri, Nicola Valeri, Hansjuerg Alder, Iouri Ivanov, Chang-Gong Liu, Carlo M Croce, Kimberly E Resnick. Am J Obstet Gynecol 2010
71
6

Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Tony K H Chung, Tak-Hong Cheung, Ngar-Yee Huen, Katherine W Y Wong, Keith W K Lo, So-Fan Yim, Nelson S S Siu, Yin-Mei Wong, Po-Ting Tsang, Man-Wah Pang,[...]. Int J Cancer 2009
127
6

miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Koichi Yoneyama, Osamu Ishibashi, Rieko Kawase, Keisuke Kurose, Toshiyuki Takeshita. Anticancer Res 2015
53
6

Risk factors for endometrial cancer: An umbrella review of the literature.
Olivia Raglan, Ilkka Kalliala, Georgios Markozannes, Sofia Cividini, Marc J Gunter, Jaya Nautiyal, Hani Gabra, Evangelos Paraskevaidis, Pierre Martin-Hirsch, Kostas K Tsilidis,[...]. Int J Cancer 2019
124
6

The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis.
Romain Delangle, Tiphaine De Foucher, Annette K Larsen, Michèle Sabbah, Henri Azaïs, Sofiane Bendifallah, Emile Daraï, Marcos Ballester, Céline Mehats, Catherine Uzan,[...]. Cancers (Basel) 2019
26
7


MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.
Xiumin Zhao, Danyang Zhu, Cailing Lu, Dewen Yan, Lifeng Li, Zhoufang Chen. Oncol Lett 2016
23
8

miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
Wei Bao, Yan Zhang, Shuangdi Li, Qiong Fan, Meiting Qiu, Yanan Wang, Yanli Li, Xiaoning Ji, Ye Yang, Zhenyu Sang,[...]. Oncol Rep 2019
10
20

Comparison of Risk Factors and survival of Type 1 and Type II Endometrial Cancers.
Tahira Y Malik, Uzma Chishti, Aliya B Aziz, Irfan Sheikh. Pak J Med Sci 2016
11
18

Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα.
Binya Liu, Qi Che, Haifeng Qiu, Wei Bao, Xiaoyue Chen, Wen Lu, Bilan Li, Xiaoping Wan. PLoS One 2014
43
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.